Genesis Healthcare Stock Price, News & Analysis (NYSE:GEN)

$1.22 -0.04 (-3.17 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$1.22
Today's Range$1.14 - $1.31
52-Week Range$0.60 - $3.45
Volume798,919 shs
Average Volume805,440 shs
Market Capitalization$190.82 million
P/E Ratio-0.25
Dividend YieldN/A
Beta1.58

About Genesis Healthcare (NYSE:GEN)

Genesis Healthcare logoGenesis Healthcare, Inc. is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities. Its services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Residential & Long Term Care
Sub-IndustryN/A
SectorHealthcare
SymbolNYSE:GEN
CUSIPN/A
Phone+1-610-4446350

Debt

Debt-to-Equity Ratio-0.22%
Current Ratio0.18%
Quick Ratio0.18%

Price-To-Earnings

Trailing P/E Ratio-0.246963562753036
Forward P/E Ratio-0.89
P/E GrowthN/A

Sales & Book Value

Annual Sales$5.73 billion
Price / Sales0.03
Cash Flow$1.11 per share
Price / Cash1.10
Book Value($4.73) per share
Price / Book-0.26

Profitability

Trailing EPS($4.94)
Net Income$-64,010,000.00
Net Margins-8.58%
Return on EquityN/A
Return on Assets-3.07%

Miscellaneous

Employees82,000
Outstanding Shares156,400,000

Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare Inc (NYSE:GEN) issued its quarterly earnings data on Thursday, November, 3rd. The company reported ($0.23) EPS for the quarter, topping the Zacks' consensus estimate of ($0.40) by $0.17. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.39 billion. Genesis Healthcare's quarterly revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.07 earnings per share. View Genesis Healthcare's Earnings History.

Where is Genesis Healthcare's stock going? Where will Genesis Healthcare's stock price be in 2018?

2 brokers have issued twelve-month target prices for Genesis Healthcare's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Genesis Healthcare's share price to reach $2.00 in the next year. View Analyst Ratings for Genesis Healthcare.

Who are some of Genesis Healthcare's key competitors?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the folowing people:

  • Robert H. Fish, Chairman of the Board (Age 66)
  • George V. Hager Jr., Chief Executive Officer, Director (Age 61)
  • Thomas DiVittorio, Chief Financial Officer (Age 49)
  • Paul David Bach, Chief Operating Officer (Age 58)
  • Jeanne Phillips, Chief Human Resource Officer, Senior Vice President
  • David C. Almquist, Executive Vice President, President - West and East Divisions (Age 62)
  • Richard P. Blinn, Executive Vice President, President - Northeast Division and Southeast Divisions (Age 62)
  • JoAnne Reifsnyder Ph.D., Executive Vice President - Clinical Operations, Chief Nursing Officer (Age 58)
  • Richard L. Castor, Senior Vice President, Chief Information Officer (Age 56)
  • Michael S. Sherman, Senior Vice President, General Counsel, Assistant Treasurer, Secretary (Age 48)

Who owns Genesis Healthcare stock?

Genesis Healthcare's stock is owned by many different of institutional and retail investors. Top institutional investors include FISHMAN STEVEN E. (57.10%), Columbia Pacific Advisors LLC (4.43%), Prescott Group Capital Management L.L.C. (1.45%), V3 Capital Management L.P. (1.45%), BlackRock Inc. (1.39%) and Renaissance Technologies LLC (0.76%). Company insiders that own Genesis Healthcare stock include Daniel Allen Hirschfeld, George V Hager Jr, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Institutional Ownership Trends for Genesis Healthcare.

Who sold Genesis Healthcare stock? Who is selling Genesis Healthcare stock?

Genesis Healthcare's stock was sold by a variety of institutional investors in the last quarter, including Columbia Pacific Advisors LLC, Forward Management LLC and BlackRock Inc.. Company insiders that have sold Genesis Healthcare company stock in the last year include Daniel Allen Hirschfeld, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View Insider Buying and Selling for Genesis Healthcare.

Who bought Genesis Healthcare stock? Who is buying Genesis Healthcare stock?

Genesis Healthcare's stock was purchased by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Renaissance Technologies LLC, Virtu Financial LLC, Millennium Management LLC and V3 Capital Management L.P.. View Insider Buying and Selling for Genesis Healthcare.

How do I buy Genesis Healthcare stock?

Shares of Genesis Healthcare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of Genesis Healthcare stock can currently be purchased for approximately $1.22.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $190.82 million and generates $5.73 billion in revenue each year. The company earns $-64,010,000.00 in net income (profit) each year or ($4.94) on an earnings per share basis. Genesis Healthcare employs 82,000 workers across the globe.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 E State St, KENNETT SQUARE, PA 19348-3109, United States. The company can be reached via phone at +1-610-4446350 or via email at [email protected]


MarketBeat Community Rating for Genesis Healthcare (GEN)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  197 (Vote Underperform)
Total Votes:  333
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Genesis Healthcare (NYSE:GEN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.502.502.502.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.00$2.00$2.00$2.65
Price Target Upside: 96.08% upside96.08% upside96.08% upside61.59% upside

Genesis Healthcare (NYSE:GEN) Consensus Price Target History

Price Target History for Genesis Healthcare (NYSE:GEN)

Genesis Healthcare (NYSE:GEN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/13/2017Royal Bank of CanadaReiterated RatingHold$2.00LowView Rating Details
7/5/2017Cantor FitzgeraldInitiated CoverageOverweightHighView Rating Details
9/19/2016Bank of AmericaSet Price TargetSell$1.80N/AView Rating Details
5/11/2016StephensDowngradeOverweight -> HoldN/AView Rating Details
(Data available from 2/24/2016 forward)

Earnings

Genesis Healthcare (NYSE:GEN) Earnings History and Estimates Chart

Earnings by Quarter for Genesis Healthcare (NYSE:GEN)

Genesis Healthcare (NYSE GEN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017($0.30)($0.36)$1.34 billion$1.32 billionViewN/AView Earnings Details
8/8/2017Q2 2017($0.26)($0.32)$1.37 billion$1.34 billionViewN/AView Earnings Details
5/9/2017Q1 17($0.25)($0.50)$1.40 billion$1.39 billionViewListenView Earnings Details
3/6/2017Q4 2016($0.64)$1.40 billionViewN/AView Earnings Details
11/3/2016Q3($0.40)($0.23)$1.39 billion$1.42 billionViewN/AView Earnings Details
8/4/2016Q2$0.01($0.26)$1.40 billion$1.44 billionViewN/AView Earnings Details
5/9/2016Q1$0.03($0.01)$1.43 billion$1.47 billionViewN/AView Earnings Details
2/22/2016Q4 2015($0.05)($0.05)$1.44 billionViewN/AView Earnings Details
11/5/2015Q315$0.07$0.07$1.42 billion$1.42 billionViewN/AView Earnings Details
8/6/2015Q215$0.09$0.14$1.43 billion$1.41 billionViewN/AView Earnings Details
5/7/2015Q1 2015$0.04$0.07$1.43 billion$1.34 billionViewN/AView Earnings Details
2/19/2015Q412$0.14$0.14$209.50 million$1.19 billionViewN/AView Earnings Details
11/3/2014Q314$0.07$0.13$208.10 million$208.60 millionViewListenView Earnings Details
8/11/2014Q214$0.06$0.07$209.15 million$207.00 millionViewListenView Earnings Details
5/5/2014Q114$0.07$0.06$210.39 million$207.30 millionViewListenView Earnings Details
2/11/2014Q413$0.10$0.06$215.35 million$208.30 millionViewListenView Earnings Details
11/4/2013Q313$0.10$0.06$214.47 million$212.40 millionViewN/AView Earnings Details
8/5/2013Q2 2013$0.16$0.09$219.58 million$213.70 millionViewN/AView Earnings Details
5/6/2013Q1 2013$0.18$0.10$222.52 million$218.90 millionViewN/AView Earnings Details
2/11/2013Q4 2012$0.19$0.16$219.67 million$219.20 millionViewN/AView Earnings Details
11/9/2012Q312$0.03$0.18$935.06 millionViewN/AView Earnings Details
11/5/2012Q312$0.20$0.21$218.92 million$216.60 millionViewN/AView Earnings Details
8/8/2012$0.19$0.18ViewN/AView Earnings Details
5/2/2012$0.19$0.17ViewN/AView Earnings Details
2/13/2012$0.15$0.19ViewN/AView Earnings Details
10/31/2011$0.30$0.32ViewN/AView Earnings Details
8/1/2011$0.31$0.30ViewN/AView Earnings Details
5/3/2011$0.30$0.34ViewN/AView Earnings Details
2/14/2011$0.28$0.31ViewN/AView Earnings Details
11/1/2010Q3 2010$0.20$0.25ViewN/AView Earnings Details
8/5/2010Q2 2010$0.21$0.24ViewN/AView Earnings Details
5/3/2010Q1 2010$0.23$0.24ViewN/AView Earnings Details
2/8/2010Q4 2009$0.23$0.25ViewN/AView Earnings Details
11/3/2009Q3 2009$0.22$0.25ViewN/AView Earnings Details
8/4/2009Q2 2009$0.25$0.25ViewN/AView Earnings Details
5/5/2009Q1 2009$0.27$0.29ViewN/AView Earnings Details
2/10/2009Q4 2008$0.27$0.28ViewN/AView Earnings Details
11/6/2008Q3 2008$0.25$0.26ViewN/AView Earnings Details
8/5/2008Q2 2008$0.24$0.24ViewN/AView Earnings Details
5/6/2008Q1 2008$0.23$0.23ViewN/AView Earnings Details
2/12/2008Q4 2007$0.23$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Genesis Healthcare (NYSE:GEN) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.37 EPS
Next Year EPS Consensus Estimate: $-1.17 EPS

Dividends

Dividend History for Genesis Healthcare (NYSE:GEN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Genesis Healthcare (NYSE GEN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 57.59%
Institutional Ownership Percentage: 19.18%
Insider Trades by Quarter for Genesis Healthcare (NYSE:GEN)
Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)

Genesis Healthcare (NYSE GEN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/14/2017Joanne Susan ReifsnyderEVPSell5,269$1.73$9,115.37View SEC Filing  
6/14/2017Michael Scott ShermanSVPSell3,903$1.73$6,752.19View SEC Filing  
6/14/2017Paul David BachCOOSell6,100$1.73$10,553.00View SEC Filing  
6/14/2017Stephen Scott YoungVPSell3,799$1.73$6,572.27View SEC Filing  
6/14/2017Thomas DivittorioCFOSell6,341$1.73$10,969.93View SEC Filing  
6/7/2017Daniel Allen HirschfeldCOOSell2,895$1.61$4,660.95View SEC Filing  
6/7/2017Joanne Susan ReifsnyderEVPSell2,383$1.61$3,836.63View SEC Filing  
6/7/2017Michael Scott ShermanSVPSell1,824$1.61$2,936.64View SEC Filing  
6/7/2017Stephen Scott YoungVPSell1,541$1.61$2,481.01View SEC Filing  
6/7/2017Thomas DivittorioCFOSell2,900$1.61$4,669.00View SEC Filing  
8/29/2016Stephen Scott YoungVPSell10,000$2.38$23,800.00View SEC Filing  
6/8/2016Daniel Allen HirschfeldCOOSell3,009$1.72$5,175.48488,220View SEC Filing  
6/8/2016George V Hager JrCEOSell6,031$1.72$10,373.321,542,780View SEC Filing  
6/8/2016Joanne Susan ReifsnyderEVPSell2,207$1.72$3,796.04286,468View SEC Filing  
6/8/2016Michael Scott ShermanSVPSell1,919$1.72$3,300.68423,220View SEC Filing  
6/8/2016Stephen Scott YoungVPSell1,621$1.72$2,788.12172,495View SEC Filing  
6/8/2016Thomas DivittorioCFOSell3,051$1.72$5,247.72509,220View SEC Filing  
11/12/2015James V MckeonDirectorBuy10,000$4.15$41,500.0029,802View SEC Filing  
11/11/2015Thomas DivittorioCFOBuy20,000$4.34$86,800.00387,220View SEC Filing  
11/14/2013Boyd HendricksonCEOSell48,774$5.02$244,845.48265,430View SEC Filing  
8/6/2013Boyd W HendricksonCEOSell4,983$6.03$30,047.49View SEC Filing  
8/5/2013Boyd W HendricksonCEOSell24,671$6.49$160,114.79View SEC Filing  
8/2/2013Boyd W HendricksonCEOSell45,346$6.58$298,376.68View SEC Filing  
7/2/2013Boyd W HendricksonCEOSell29,988$6.46$193,722.48View SEC Filing  
7/1/2013Boyd W HendricksonCEOSell28,112$6.61$185,820.32View SEC Filing  
11/1/2012Boyd W HendricksonCEOSell1,567$8.00$12,536.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Genesis Healthcare (NYSE GEN) News Headlines

Source:
DateHeadline
[$$] Genesis Healthcare Refinances Debt Load Amid Restructuring[$$] Genesis Healthcare Refinances Debt Load Amid Restructuring
finance.yahoo.com - February 23 at 5:44 PM
Shares in U.S. senior housing chains Genesis, Brookdale slideShares in U.S. senior housing chains Genesis, Brookdale slide
www.reuters.com - February 23 at 8:37 AM
Welltower Reports Fourth Quarter 2017 ResultsWelltower Reports Fourth Quarter 2017 Results
www.bizjournals.com - February 22 at 5:28 PM
Genesis Healthcare gets some debt reliefGenesis Healthcare gets some debt relief
finance.yahoo.com - February 22 at 5:28 PM
Asset Sales Continue Holding Down Welltower Inc's ResultsAsset Sales Continue Holding Down Welltower Inc's Results
finance.yahoo.com - February 22 at 5:28 PM
With A -32.62% Earnings Drop Lately, Did Genesis Healthcare Inc (NYSE:GEN) Underperform Its Industry?With A -32.62% Earnings Drop Lately, Did Genesis Healthcare Inc (NYSE:GEN) Underperform Its Industry?
finance.yahoo.com - February 20 at 5:35 PM
BRIEF-Genesis Healthcare To Extend "Lock-Up" Period Of Shares Until July 31BRIEF-Genesis Healthcare To Extend "Lock-Up" Period Of Shares Until July 31
www.reuters.com - February 16 at 5:10 PM
Genesis Healthcare (GEN) Scheduled to Post Quarterly Earnings on TuesdayGenesis Healthcare (GEN) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - February 13 at 2:56 AM
Blockchain Technology May Change the World, But What Are the Risks?Blockchain Technology May Change the World, But What Are the Risks?
www.thestreet.com - February 10 at 9:38 AM
Nursing home giant Genesis eyes approval for $26M Dracut facilityNursing home giant Genesis eyes approval for $26M Dracut facility
finance.yahoo.com - February 9 at 9:46 AM
Genesis HealthCare to Present at the 36th Annual J. P. Morgan Healthcare Conference on January 11, 2018Genesis HealthCare to Present at the 36th Annual J. P. Morgan Healthcare Conference on January 11, 2018
finance.yahoo.com - January 3 at 5:01 PM
ETFs with exposure to Genesis Healthcare, Inc. : January 1, 2018ETFs with exposure to Genesis Healthcare, Inc. : January 1, 2018
finance.yahoo.com - January 1 at 4:53 PM
ETFs with exposure to Genesis Healthcare, Inc. : December 19, 2017ETFs with exposure to Genesis Healthcare, Inc. : December 19, 2017
finance.yahoo.com - December 19 at 4:57 PM
Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 4:55 PM
Humana in talks to buy Kindred Healthcare with equity firms: sourceHumana in talks to buy Kindred Healthcare with equity firms: source
www.reuters.com - December 17 at 5:01 PM
Millennium Health Appoints Robert H. Fish as Interim Chief Executive OfficerMillennium Health Appoints Robert H. Fish as Interim Chief Executive Officer
finance.yahoo.com - December 14 at 5:31 PM
156 Genesis HealthCare Sites Earn National Quality Improvement Recognition156 Genesis HealthCare Sites Earn National Quality Improvement Recognition
finance.yahoo.com - December 11 at 5:09 PM
Five Star Quality Care (FVE) and Genesis Healthcare (GEN) Financial SurveyFive Star Quality Care (FVE) and Genesis Healthcare (GEN) Financial Survey
www.americanbankingnews.com - December 9 at 11:42 PM
Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE - GlobeNewswire (press release)Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE - GlobeNewswire (press release)
globenewswire.com - November 30 at 9:06 AM
Assessing the Recent Volatility in Bitcoin - Presented by: The Aol. On NetworkAssessing the Recent Volatility in Bitcoin - Presented by: The Aol. On Network
www.nasdaq.com - November 29 at 5:18 PM
Genesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSEGenesis Healthcare, Inc. Receives Continued Listing Standard Notice From the NYSE
finance.yahoo.com - November 29 at 5:18 PM
Weekly CFO Buys HighlightWeekly CFO Buys Highlight
finance.yahoo.com - November 25 at 4:24 PM
HCR ManorCare gets respite from dropped Medicare fraud lawsuit - ReutersHCR ManorCare gets respite from dropped Medicare fraud lawsuit - Reuters
www.reuters.com - November 21 at 5:38 AM
Head to Head Review: Genesis Healthcare (GEN) versus Five Star Quality Care (FVE)Head to Head Review: Genesis Healthcare (GEN) versus Five Star Quality Care (FVE)
www.americanbankingnews.com - November 15 at 5:08 AM
Sabra Provides Update on Genesis Exodus; Reaffirms 2017 and 2018 GuidanceSabra Provides Update on Genesis Exodus; Reaffirms 2017 and 2018 Guidance
finance.yahoo.com - November 14 at 12:15 AM
Genesis Healthcare sees nursing home lease deals saving cash - ReutersGenesis Healthcare sees nursing home lease deals saving cash - Reuters
www.reuters.com - November 11 at 5:45 AM
Edited Transcript of GEN earnings conference call or presentation 9-Nov-17 1:30pm GMTEdited Transcript of GEN earnings conference call or presentation 9-Nov-17 1:30pm GMT
finance.yahoo.com - November 11 at 5:45 AM
Genesis HealthCare Announces Plans to Strengthen Capital Structure and Reports Third Quarter 2017 ResultsGenesis HealthCare Announces Plans to Strengthen Capital Structure and Reports Third Quarter 2017 Results
finance.yahoo.com - November 9 at 5:37 AM
Genesis Healthcare reports 3Q lossGenesis Healthcare reports 3Q loss
finance.yahoo.com - November 9 at 5:37 AM
Genesis Automation Receives Innovative Technology Designation from Vizient for its Supply Traceability PlatformGenesis Automation Receives Innovative Technology Designation from Vizient for its Supply Traceability Platform
www.businesswire.com - November 8 at 7:56 AM
Genesis HealthCare to Release Third Quarter 2017 Results on Wednesday, November 8, 2017Genesis HealthCare to Release Third Quarter 2017 Results on Wednesday, November 8, 2017
finance.yahoo.com - November 8 at 7:56 AM
ETFs with exposure to Genesis Healthcare, Inc. : November 6, 2017ETFs with exposure to Genesis Healthcare, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 12:52 AM
Sabra Healthcare Q3: Dividend Hike And Focus On QualitySabra Healthcare Q3: Dividend Hike And Focus On Quality
seekingalpha.com - November 3 at 11:40 AM
Sabra Reports Third Quarter 2017 Results and Improved Balance ... - GlobeNewswire (press release)Sabra Reports Third Quarter 2017 Results and Improved Balance ... - GlobeNewswire (press release)
globenewswire.com - November 2 at 1:18 AM
Tissue Genesis LLC, and Human Life CORD Japan, Inc., Announce Exclusive Agreement to Advance Adult Stem Cell Therapies in AsiaTissue Genesis LLC, and Human Life CORD Japan, Inc., Announce Exclusive Agreement to Advance Adult Stem Cell Therapies in Asia
finance.yahoo.com - November 1 at 1:12 AM
LTC Properties Vs. Omega Healthcare: Battle Of The Healthcare REITsLTC Properties Vs. Omega Healthcare: Battle Of The Healthcare REITs
seekingalpha.com - October 31 at 5:56 AM
ETFs with exposure to Genesis Healthcare, Inc. : October 25, 2017ETFs with exposure to Genesis Healthcare, Inc. : October 25, 2017
finance.yahoo.com - October 26 at 7:54 AM
Have Investors Already Priced In Genesis Healthcare Inc’s (GEN) Growth?Have Investors Already Priced In Genesis Healthcare Inc’s (GEN) Growth?
finance.yahoo.com - October 26 at 7:54 AM
Thursday Sector Leaders: Hospital & Medical Practitioners, Agriculture & Farm ProductsThursday Sector Leaders: Hospital & Medical Practitioners, Agriculture & Farm Products
www.nasdaq.com - October 20 at 12:50 AM
Felicia Chew of Genesis Rehab Services Approved as Co-Principal Investigator in $4.7 Million Funding AwardFelicia Chew of Genesis Rehab Services Approved as Co-Principal Investigator in $4.7 Million Funding Award
finance.yahoo.com - October 17 at 7:42 PM
US Nursing Home Chain Faces Landlord Showdown Over Default - New York TimesUS Nursing Home Chain Faces Landlord Showdown Over Default - New York Times
www.nytimes.com - October 16 at 3:17 PM
ETFs with exposure to Genesis Healthcare, Inc. : October 13, 2017ETFs with exposure to Genesis Healthcare, Inc. : October 13, 2017
finance.yahoo.com - October 13 at 4:37 PM
Seeking Alpha With OmegaSeeking Alpha With Omega
seekingalpha.com - October 9 at 7:11 PM
Why We Are Ready To Make This REIT Our Largest PositionWhy We Are Ready To Make This REIT Our Largest Position
seekingalpha.com - October 4 at 5:54 PM
Sensoria Partners with Genesis Rehab Services to Deliver Healthcare Solutions to the Smart Aging PatientSensoria Partners with Genesis Rehab Services to Deliver Healthcare Solutions to the Smart Aging Patient
finance.yahoo.com - October 4 at 11:28 AM
Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017Genesis Healthcare, Inc. :GEN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
finance.yahoo.com - October 2 at 2:11 PM
ETFs with exposure to Genesis Healthcare, Inc. : October 2, 2017ETFs with exposure to Genesis Healthcare, Inc. : October 2, 2017
finance.yahoo.com - October 2 at 2:11 PM
Devonian Health Announces Purgenesis™ anti-aging treatment marketing and distribution partnershipDevonian Health Announces Purgenesis™ anti-aging treatment marketing and distribution partnership
globenewswire.com - September 28 at 6:14 PM
BRIEF-Sabra moves through Sabra 2.0 with the CCP acquisition to Sabra 3.0BRIEF-Sabra moves through Sabra 2.0 with the CCP acquisition to Sabra 3.0
www.reuters.com - September 25 at 5:29 PM
Genesis Healthcare To Present Cantor Fitzgerald Conference; Webcast At 3:00 PMGenesis Healthcare To Present Cantor Fitzgerald Conference; Webcast At 3:00 PM
www.nasdaq.com - September 25 at 5:29 PM

SEC Filings

Genesis Healthcare (NYSE:GEN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Genesis Healthcare (NYSE:GEN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Genesis Healthcare (NYSE GEN) Stock Chart for Saturday, February, 24, 2018

Loading chart…

This page was last updated on 2/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.